CoChat
Sign Up
Cited by 192

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer

Wang, Xinyi, Zhang, Haiyang, Bai, Ming, Ning, Tao, Ge, Shaohua, Deng, Ting, Liu, Rui, Zhang, Le, Ying, Guoguang, Ba, Yi·2018·Molecular Therapy
DOI 10.1016/j.ymthe.2018.01.001
Open this paper in CoChat — free account

Abstract

Chemoresistance is one of the causes of adverse effects in gastric cancer, including a poor response to cisplatin (DDP). Exosomes loaded with microRNA (miRNA), mRNA, and other non-coding RNAs could regulate drug resistance. Exo-anti-214 was extracted and verified. A Cell Counting Kit-8 (CCK-8) cell viability assay, flow cytometry, and transwell and immunofluorescence assays were performed to determine whether exo-anti-214 could sensitize cells to DDP in vitro. A combination of intravenously injected exo-anti-214 and intraperitoneal DDP was utilized in vivo. Additionally, potential targets of miR-214 were screened by mass spectrometry (MS) and confirmed via western blotting (WB). The levels of miR-214 in the human immortalized gastric epithelial cell line ges-1 and the human gastric adenocarcinoma cell lines SGC7901 and SGC7901/DDP gradually increased. Exo-anti-214 could fuse with cells and regulate potential targets, reducing cell viability, suppressing migration, and promoting apoptosis in vitro. Caudally injected exo-anti-214 was applied to reverse chemoresistance and repress tumor growth in vivo due to the downregulation of miR-214 and overexpression of possible target proteins in tumors. Exo-anti-214 could reverse the resistance to DDP in gastric cancer, which might serve as a potential alternative for the treatment of cisplatin-refractory gastric cancer in the future.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2018.01.001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 37

  1. Digklia, 2016, Advanced gastric cancer: current treatment landscape and future perspectives, World J. Gastroenterol., 22, 2403, 10.3748/wjg.v22.i8.2403 · DOI
  2. Cho, 2014, VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance, Int. J. Cancer, 135, 1553, 10.1002/ijc.28801 · DOI
  3. Marin, 2016, Mechanisms of resistance to chemotherapy in gastric cancer, Anticancer. Agents Med. Chem., 16, 318, 10.2174/1871520615666150803125121 · DOI
  4. Fojo, 2007, Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs, Drug Resist. Updat., 10, 59, 10.1016/j.drup.2007.02.002 · DOI
  5. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  6. Penna, 2015, miR-214 as a key hub that controls cancer networks: small player, multiple functions, J. Invest. Dermatol., 135, 960, 10.1038/jid.2014.479 · DOI
  7. Lee, 2009, Twist-1 regulates the miR-199a/214 cluster during development, Nucleic Acids Res., 37, 123, 10.1093/nar/gkn920 · DOI
  8. Wang, 2014, Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer, Br. J. Cancer, 110, 1199, 10.1038/bjc.2014.14 · DOI
  9. Zhang, 2010, Dysregulation of miR-15a and miR-214 in human pancreatic cancer, J. Hematol. Oncol., 3, 46, 10.1186/1756-8722-3-46 · DOI
  10. Yanaihara, 2006, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, 9, 189, 10.1016/j.ccr.2006.01.025 · DOI · Paper page
  11. Wang, 2014, Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma, Pediatr. Blood Cancer, 61, 206, 10.1002/pbc.24763 · DOI
  12. Yang, 2008, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res., 68, 425, 10.1158/0008-5472.CAN-07-2488 · DOI
  13. Wang, 2012, MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines, Asian Pac. J. Cancer Prev., 13, 255, 10.7314/APJCP.2012.13.1.255 · DOI
  14. Zheng, 2017, Prognostic role of microRNAs in human gastrointestinal cancer: a systematic review and meta-analysis, Oncotarget, 8, 46611, 10.18632/oncotarget.16679 · DOI
  15. Liu, 2017, Prognostic value of microRNA signature in patients with gastric cancers, Sci. Rep., 7, 42806, 10.1038/srep42806 · DOI
  16. Ueda, 2010, Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis, Lancet Oncol., 11, 136, 10.1016/S1470-2045(09)70343-2 · DOI
  17. Yang, 2013, MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN, Cancer Cell Int., 13, 68, 10.1186/1475-2867-13-68 · DOI
  18. Xin, 2016, MicroRNA-214 promotes peritoneal metastasis through regulating PTEN negatively in gastric cancer, Clin. Res. Hepatol. Gastroenterol., 40, 748, 10.1016/j.clinre.2016.05.006 · DOI
  19. Zhang, 2015, Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis, Am. J. Cancer Res., 5, 821
  20. Zhang, 2016, The effect of antisense inhibitor of miRNA 106b ∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell, Tumour Biol., 37, 10507, 10.1007/s13277-016-4937-x · DOI
  21. Harris, 2001, Pegylation: a novel process for modifying pharmacokinetics, Clin. Pharmacokinet., 40, 539, 10.2165/00003088-200140070-00005 · DOI
  22. Nakanishi, 2014, Bioactive nanocarbon assemblies: nanoarchitectonics and applications, Nano Today, 9, 378, 10.1016/j.nantod.2014.05.002 · DOI
  23. Yang, 2015, Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery, Chem. Soc. Rev., 44, 1416, 10.1039/C4CS00155A · DOI
  24. Ingato, 2016, Good things come in small packages: overcoming challenges to harness extracellular vesicles for therapeutic delivery, J. Control. Release, 241, 174, 10.1016/j.jconrel.2016.09.016 · DOI
  25. Batrakova, 2015, Using exosomes, naturally-equipped nanocarriers, for drug delivery, J. Control. Release, 219, 396, 10.1016/j.jconrel.2015.07.030 · DOI · Paper page
  26. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  27. EL Andaloussi, 2013, Extracellular vesicles: biology and emerging therapeutic opportunities, Nat. Rev. Drug Discov., 12, 347, 10.1038/nrd3978 · DOI · Paper page
  28. Vlassov, 2012, Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials, Biochim. Biophys. Acta, 1820, 940, 10.1016/j.bbagen.2012.03.017 · DOI
  29. Ohno, 2013, Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 · DOI · Paper page
  30. Zhang, 2016, Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma, Cancer Lett., 375, 331, 10.1016/j.canlet.2016.03.026 · DOI
  31. Wang, 2013, microRNA expression profiling in multidrug resistance of the 5-Fu-induced SGC-7901 human gastric cancer cell line, Mol. Med. Rep., 7, 1506, 10.3892/mmr.2013.1384 · DOI
  32. Shang, 2014, miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1, Oncogene, 33, 3267, 10.1038/onc.2013.297 · DOI
  33. Thomas, 2003, Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet., 4, 346, 10.1038/nrg1066 · DOI · Paper page
  34. Lou, 2015, Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma, J. Hematol. Oncol., 8, 122, 10.1186/s13045-015-0220-7 · DOI · Paper page
  35. Stiff, 2004, ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation, Cancer Res., 64, 2390, 10.1158/0008-5472.CAN-03-3207 · DOI
  36. Rothkamm, 2015, DNA damage foci: meaning and significance, Environ. Mol. Mutagen., 56, 491, 10.1002/em.21944 · DOI
  37. Lobb, 2015, Optimized exosome isolation protocol for cell culture supernatant and human plasma, J. Extracell. Vesicles, 4, 27031, 10.3402/jev.v4.27031 · DOI

Cited by

Sorted by citations

See all 192

Metadata

Authors
Wang, X., Zhang, H., Bai, M., Ning, T., Ge, S., Deng, T., Liu, R., Zhang, L., Ying, G., & Ba, Y.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2018-03
Volume
26
Issue
3
Pages
774-783
ISSN
1525-0016
DOI
10.1016/j.ymthe.2018.01.001
Cited by
192
References
2
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81602158, 81602156, 81702437, 81702431, 81772629, 81772843)
  • Tianjin Health and Family Planning Commission Foundation of Science and Technology (15KG142)
  • Nature Science Foundation of Tianjin City (16PTSYJC00170)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review